Emelia J. Benjamin, MD, ScM
Professor of Medicine, BUSM, Professor of Epidemiology, BUSPH
AB, Harvard University, Boston, MA, Psychology and Social Relations
MD, Case Western Reserve University School of Medicine, Cleveland, OH.
Medicine ScM, Harvard University School of Public Health, Boston, MA, Epidemiology
General field of research:
Cardiovascular Epidemiology and Cardiovascular Genetics
Affiliations other than medicine:
Evans Center for Interdisciplinary Biomedical Research
The Framingham Heart Study Section of Preventive Medicine
Section of Cardiology Whitaker Cardiovascular Institute
Epidemiology Department, Boston University School of Public Health
Phone: (617)-638 8968
The Framingham Heart Study, 73 Mount Wayte Avenue, Suite 2, Framingham, MA 01702-5827
Phone: (508)-935 3487
Fax: (617)-638 8969
Other research websites:
Research group information
The Framingham Heart Study Fellowship Program
Atrial fibrillation; Epidemiology risk factors; Inflammation; Endothelial function; Cardiovascular disease
Summary of research interest:
Emelia J. Benjamin, MD, ScM, FACC, FAHA, is a Professor of Medicine and Epidemiology at the Framingham Heart Study. She is author of over 200 peer-reviewed publications that focus on the on the genetics, epidemiology, and prognosis of a variety of cardiovascular conditions and markers including atrial fibrillation, echocardiographic findings, vascular function and systemic inflammation. She is Principal Investigator on 3 RO1 grants [1R01HL092577-01A1, 1R01 AG028321; HL076784]. Her grants examine the epidemiology and genetics of atrial fibrillation and inflammation.
In addition to her research, in the BU, Department of Medicine she serves as Vice Chair for Faculty Development and Diversity, and she is an Associate Editor for Circulation. For AHA she is Vice-Chair For the Functional Genomic’s and Translational Biology Council. She is a Chartered member of NIH Cardiovascular and Sleep Epidemiology Study Section.
Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. 1994. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA; 271:840-4. PM:8114238
Benjamin EJ, Wolf PA, et. al. 1998. Impact of atrial fibrillation on the risk of death. Circulation; 98:946-52. PM:9737513
Wang TJ, Larson MG, Levy D, …Benjamin EJ. 2003. The Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality. Circulation; 107;2920-5. PM:12771006
Fox CS, Parise H, D’Agostino RB, Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA, Benjamin EJ. 2004. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA; 291:2851-2855. PM:15199036
Lloyd-Jones DM, Wang TJ, Leip EP, Benjamin EJ. 2004. Lifetime risk for development of atrial fibrillation: Framingham Heart Study. Circulation; 110:1042-6. PM:15313941
Wang TJ, Parise H, Levy D, D’Agostino RB, Sr., Wolf PA, Vasan RS,* Benjamin EJ.* 2004. Obesity and the risk of new-onset atrial fibrillation. JAMA; 292:2471-2477. PM:15562125
Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A,…Ellinor PT, …Heckbert SR, Wyse DG. 2009. Prevention of Atrial Fibrillation: Report from an NHLBI Workshop. Circulation; 119:606-618. PM:19188521
Schnabel RB, Sullivan LM, … Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ. 2009. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort Lancet; 373:739-745. PM:19249635
Benjamin, EJ, Rice KM, Arking DE, Pfeufer A, van NC, Smith AV, Lunetta KL, Heckbert SR, Gudnason V, Alonso A, Kaab S, Ellinor PT, Witteman J. 2009. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. PM: 19597492
For a complete list of Dr. Benjamin’s publications on PubMed, click here.
Technologies available for sharing upon request:
Genome-wide association Data at dbGap.